A tool that uses artificial intelligence to help diagnose men with prostate cancer and guide decisions about treatment is to be tested in NHS hospitals, researchers have announced.
The £1.9m Vanguard Path study, funded by Prostate Cancer UK and…
Continue Reading
News Source: www.theguardian.com

Leave a Reply